Patients with previously undiagnosed diabetes are more than twice as likely to die from COVID-19, reports a new study. The findings of the study are published in the journal Diabetologia. The study is by Dr. Yang Jin, Union Hospital and Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, and colleagues. Previous studies have established that hyperglycemia (abnormally high blood sugar) is associated with an elevated risk of mortality in community-acquired pneumonia, stroke, heart attacks, trauma, and surgery, among other conditions. A number of studies have also shown links between diabetes and poor outcomes in COVID-19 patients. However, a direct correlation between fasting blood glucose (FBG) level at admission to hospital and clinical outcomes of COVID-19 patients without diagnosed diabetes has not been well established. In this new study, the authors examined the association between FBG on admission and the 28-day mortality of COVID-19 patients without previously diagnosed diabetes in two hospitals. ‘Higher fasting blood sugar at admission is an independent predictor for 28-day mortality in COVID-19 patients without a previous diagnosis of diabetes. ’ The retrospective study assessed all consecutive COVID-19 patients with a known outcome at 28-days and FBG measurement at admission from 24 January 2020 to 10 February 2020 in two hospitals based in Wuhan, China. Demographic and clinical data, 28-day outcomes, in-hospital complications, and CRB-65 scores of COVID-19 patients in the two hospitals were analyzed. The CRB-65 score is an effective measure for assessing the severity of pneumonia and is based on four indicators: level of confusion, respiratory rate (over 30 breaths per min), systolic blood pressure (90 mmHg or less) or diastolic blood pressure (60 mmHg or less), and age (65 years or over). A total of 605 COVID-19 patients were enrolled, including 114 who died in hospital. The median age of participants was 59 years, and 322 (53.2%) were men. A total of 208 (34%) had one or more underlying conditions (but not diagnosed diabetes), of which high blood pressure was the most common. Almost one third (29%) of patients fell into the highest category of FBG on admission (7.0 mmol/L) which, if found consistently, would result in a diagnosis of type 2 diabetes. A further 17% were in the range that would be considered pre-diabetic (6.1-6.9 mmol/L), while more than half (54%) were in the 'normal' FBG range of 6.0 mmol/L or below. The results showed that patients in the highest FBG group were 2.3 times more likely to die than those in the lowest, a statistically significant result. Those in the middle (pre-diabetic) FBG group were 71% more likely to die than those in the lowest group, although this result only had borderline statistical significance. The data also showed that men were 75% more likely to die than women; and that patients with higher CRB65 scores (and thus worse pneumonia) were also at higher risk of death: those with a score of 3-4 were more than five times more likely to die than those with a score of 0, while for those with a score of 1-2 there were a 2.7 times increased risk. When looking at FBG and CRB65 scores together, the patients in the highest FBG group had an increased risk of death compared to the lowest, regardless of whether or not the CRB65 score was zero or higher, further underlining that FBG independently increases the risk of death in COVID-19 patients. However, the increased risk of death for the highest FBG group was lower in patients with CRB65 scores of above zero compared with those with a CRB65 score of zero. The risk of complications was also found to be four times higher in the highest FBG group compared to the lowest, and 2.6 times higher in the middle (pre-diabetic) group compared to the lowest. The authors say: "This study shows, for the first time, that elevated FBG (?7.0 mmol/l) at admission is independently associated with increased 28-day mortality and percentages of in-hospital complications in COVID-19 patients without a previous diagnosis of diabetes... we have also shown that FBG of 7.0 mmol/l or higher is associated with increased mortality, regardless of whether the patient has pneumonia that is more or less severe." They add: "These results indicate that our study included both undiagnosed diabetic patients and non-diabetic patients with hyperglycemia caused by an acute blood-glucose disorder since the 29% found in the highest FBG group is much higher than the estimated prevalence of diabetes in the Chinese population at 12%. Similar to what was found in a previous study, COVID-19 patients might suffer from high blood sugar brought about by other conditions, and critically ill patients may develop acute insulin resistance, manifested by high levels of blood sugar and insulin levels. Patients with conditions not related to diabetes, such as severe sepsis, systemic inflammatory response syndrome (SIRS), and traumatic brain injury tend to have abnormally high blood sugar." The authors note several limitations to their study. First, this was a retrospective study. Second, they did not analyze glycated haemoglobin (HbA1c), a long-term blood sugar control indicator that helps distinguish patients with poor long-term blood sugar control from those with stress hyperglycemia. Also, they did not have sufficient data to study the effect of glucose-lowering treatment (e.g., insulin, metformin) on the outcome of the patients in their study. However, they believe that acute hyperglycemia is more important than long-term glycaemic control in predicting the prognosis of hospitalized COVID-19 patients. The authors suggest that possible mechanisms for this increased mortality include hyperglycemia-induced changes in coagulation (clotting), worsening of endothelial function (the function of the walls of blood vessels), and overproduction of inflammatory cytokines produced by the immune system (the so-called cytokine storm). The authors conclude: "In conclusion, a fasting blood glucose level of 7.0 mmol/l or higher at admission is an independent predictor for 28-day mortality in patients with COVID-19 without a previous diagnosis of diabetes. Blood sugar testing and control should be recommended to all COVID-19 patients even if they do not have pre-existing diabetes, as most COVID-19 patients are prone to glucose metabolic disorders. During a pandemic of COVID-19, measuring fasting blood glucose can facilitate the assessment of prognosis and early intervention of hyperglycemia to help improve the overall outcomes in the treatment of COVID-19."Source: Eurekalert << COVID-19 Infection can be Transmitted in the Womb, Study Drug May Help to Extend Lifespan in Humans >> Recommended Reading Coronavirus Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus. READ MORE Watch Out: Deadly Coronavirus may Lurk in Kids’ Toys and Play Equipment Stay away from playgrounds: COVID-19 can stick on to kids' toys and play equipment. So, make your naughty kids to play indoors and avoid sharing toys to keep coronavirus at bay. READ MORE COVID-19 Pandemic: Simple Ideas to Help Kids Deal with Stress during Coronavirus Crisis Staying indoors all day and social distancing during COVID-19 lockdown can wreak havoc on your child's mental health. Here are a few simple tips to help kids to beat stress and overcome boredom during coronavirus crisis. READ MORE Coronavirus Outbreak: 5 Ways to Keep Your Hands from Drying and Cracking Hand hygiene is the most important thing right now due to coronavirus outbreak. Frequent washing can make your skin dry and cracked. Here are five tips that help keep your hands from drying and cracking. READ MORE Bereavement Bereavement is a word used to denote grief, pain and sadness following the loss of a loved one. READ MORE Carbohydrates and Its Role in Obesity Obesity is a global epidemic with majority of the world’s population in developed countries being over weight or obese! READ MORE Decoding HbA1c Test for Blood Sugar The HbA1c assay is the gold-standard measurement of chronic glycemia and measures the amount of glucose that binds to hemoglobin over a period of 3 months READ MORE Diabetes - Essentials Diabetes is a metabolic disease caused by insulin deficiency that leads to high blood sugar levels and several associated complications if left untreated. READ MORE Diabetes - Self-Monitoring of Blood Glucose (SMBG) Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Diabetes. READ MORE Hunger Fullness and Weight Control An erratic way of eating or any metabolic disturbance in the hunger fullness signals is one of the major causes of obesity. READ MORE Sugar: Time to Look beyond Its Sweetness Sugar is known to be the dietary cause for increased risk of several chronic ailments such as diabetes and cancer. Is it coincidence or is it for real? READ MORE Thalassemia Thalassemia is an inherited blood disorder passed on through parental genes causing the body to produce abnormal hemoglobin. READ MORE The Better Flour - Refined Or Whole Wheat Flour! Whole wheat flour is rapidly gaining exposure for its rich nutritional value and being considered healthy, as opposed to all-purpose flour, maida. READ MORE Most Popular on Medindia Calculate Ideal Weight for Infants Blood Pressure Calculator Vent Forte (Theophylline) More News on: ThalassemiaDiabetes - EssentialsDiabetes - Self-Monitoring of Blood Glucose (SMBG)Death FactsBereavementDecoding HbA1c Test for Blood SugarHunger Fullness and Weight ControlCarbohydrates and Its Role in ObesitySugar: Time to Look beyond Its SweetnessThe Better Flour - Refined Or Whole Wheat Flour!